---
schema_version: "secwatch.filing_event.v1"
accession: "0001822359-26-000017"
form_type: "8-K"
ticker: "DCGO"
cik: "0001822359"
company_name: "DocGo Inc."
filed_at: "2026-04-22T23:59:59+00:00"
generated_at: "2026-05-15T04:55:51.743983+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# DocGo: Director Klasko to step down; Burdiek named independent Chair; special committee for cost reduction

## Summary
- Dr. Stephen Klasko will step down from the Board effective after the 2026 Annual Meeting on June 16, 2026, due to a new healthcare leadership role.
- Klasko's departure was not due to any disagreement with DocGo regarding operations, disclosures, policies, or practices.
- Michael Burdiek, an independent director, was appointed as independent Chair of the Board, effective at the same time as Klasko's departure.
- Jim Travers was appointed to the Audit and Compliance Committee and the Nominating and Corporate Governance Committee, replacing Klasko immediately prior to the effective time.
- On April 21, 2026, the Board formed a special committee (Vina Leite, Ira Smedra, Michael Burdiek) to identify corporate efficiencies and cost reduction opportunities.

## SEC filing metadata
- accession: 0001822359-26-000017
- form_type: 8-K
- ticker: DCGO
- cik: 0001822359
- company_name: DocGo Inc.
- filed_at: 2026-04-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822359/000182235926000017/0001822359-26-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822359/000182235926000017/dcgo-20260417.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822359-26-000017
- JSON: https://secwatch.observer/filing/0001822359-26-000017.json
- Plain text: https://secwatch.observer/filing/0001822359-26-000017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.